MXPA02011018A - Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals. - Google Patents

Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals.

Info

Publication number
MXPA02011018A
MXPA02011018A MXPA02011018A MXPA02011018A MXPA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A
Authority
MX
Mexico
Prior art keywords
treatment
hypertension
mammals
production
resulting products
Prior art date
Application number
MXPA02011018A
Other languages
Spanish (es)
Inventor
Anand Rao
Original Assignee
Davisco Internat Foods Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/567,283 external-priority patent/US6630320B1/en
Priority claimed from US09/702,068 external-priority patent/US6998259B1/en
Application filed by Davisco Internat Foods Inc filed Critical Davisco Internat Foods Inc
Publication of MXPA02011018A publication Critical patent/MXPA02011018A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Enzymatic digests of whey protein concentrates were prepared using animal, bacterial and fungal proteases, and evaluated for antihypertensive activities. ACE inhibitory activity and antihypertension activity were obtained with a hydrolysate of whey protein isolate prepared with a porcine trypsin.
MXPA02011018A 2000-05-08 2001-05-08 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals. MXPA02011018A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/567,283 US6630320B1 (en) 2000-05-08 2000-05-08 Treatment of hypertension in mammals with hydrolyzed whey proteins
US09/702,068 US6998259B1 (en) 1999-05-20 2000-10-30 Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products
PCT/US2001/014797 WO2001085984A1 (en) 2000-05-08 2001-05-08 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals

Publications (1)

Publication Number Publication Date
MXPA02011018A true MXPA02011018A (en) 2004-08-19

Family

ID=27074429

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011018A MXPA02011018A (en) 2000-05-08 2001-05-08 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals.

Country Status (7)

Country Link
EP (1) EP1287159A4 (en)
JP (1) JP2004519204A (en)
AU (1) AU2001259625A1 (en)
CA (1) CA2415688A1 (en)
MX (1) MXPA02011018A (en)
NZ (1) NZ523036A (en)
WO (1) WO2001085984A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919314B1 (en) 1998-06-17 2005-07-19 New Zealand Dairy Board Bioactive whey protein hydrolysate
JP2005538704A (en) 2002-07-01 2005-12-22 ユニリーバー・ナームローゼ・ベンノートシヤープ Satiety-inducing composition
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
EP1466529A1 (en) * 2003-04-07 2004-10-13 Chr. Hansen A/S Composition with heart rate reducing properties
US20060216330A1 (en) * 2003-05-05 2006-09-28 Janssen Johannes G Peptides having an ace inhibiting effect
ES2253036B1 (en) 2003-07-31 2007-07-16 Consejo Sup. Investig. Cientificas BIOACTIVE PEPTIDES DERIVED FROM PROTEINS OF THE EGG CLEAR BY ENZYMATIC HYDROLYSIS.
RU2006125434A (en) * 2003-12-15 2008-01-27 Юнилевер Н.В. (Nl) PEPTIDES WITH ACE-INHIBITING ACTION
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
NL1026931C2 (en) * 2004-08-31 2006-03-01 Friesland Brands Bv ACE-inhibiting whey hydrolysates.
WO2006024673A1 (en) 2004-09-03 2006-03-09 Chr. Hansen A/S Fermented milk or vegetable proteins comprising receptor ligand and uses thereof
FR2876389B1 (en) * 2004-10-13 2007-05-25 Viridis Sa HYDROLYSATS OF WHITE PROTEINS FROM LUZERNE
ES2319475B1 (en) 2005-06-08 2010-02-16 Consejo Superior Investig. Cientificas BIOACTIVE PEPTIDES IDENTIFIED IN ENZYMATIC HYDROLYZES OF LACTEE CASEINS AND PROCEDURE OF OBTAINING.
DE102008032828A1 (en) 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophan-containing peptides from alpha-lactalbumin with hypotensive and vasoprotective action for biofunctional foods
EA035522B1 (en) 2013-04-25 2020-06-29 Янссен Вэксинс Энд Превеншн Б.В. Stabilized soluble prefusion rsv f polypeptides
US10457708B2 (en) 2015-07-07 2019-10-29 Janssen Vaccines & Prevention B.V. Stabilized soluble pre-fusion RSV F polypeptides
EP3821906A1 (en) 2015-07-07 2021-05-19 Janssen Vaccines & Prevention B.V. Vaccine against rsv comprising modified f polypeptide
IL262109B2 (en) 2016-04-05 2023-04-01 Janssen Vaccines Prevention B V Vaccine against rsv
PE20190420A1 (en) 2016-04-05 2019-03-19 Janssen Vaccines And Prevention B V SOLUBLE AND STABILIZED RESPIRATORY SYNCITIAL VIRUS (RSV) PREFUSION PROTEINS F
MY194419A (en) 2016-05-30 2022-11-30 Janssen Vaccines & Prevention Bv Stabilized pre-fusion rsv f proteins
WO2018210871A1 (en) 2017-05-17 2018-11-22 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against rsv infection
EP3624844A1 (en) 2017-05-17 2020-03-25 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against rsv infection
MX2020002876A (en) 2017-09-15 2020-07-22 Janssen Vaccines & Prevention Bv Method for the safe induction of immunity against rsv.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3149199B2 (en) * 1991-03-12 2001-03-26 カルピス株式会社 Angiotensin converting enzyme inhibitory peptide
JP3091772B2 (en) * 1991-03-12 2000-09-25 カルピス株式会社 Angiotensin converting enzyme inhibiting peptide composition
US5744179A (en) * 1992-11-30 1998-04-28 Morinaga Milk Industry Co., Ltd. Low-phosphorus whey protein, manufacturing method thereof, low-phosphorus purified whey hydrolysate and manufacturing method thereof
JPH06345664A (en) * 1993-06-11 1994-12-20 Takako Tomita New composition for suppressing elevation of blood pressure
JPH1033115A (en) * 1996-07-24 1998-02-10 Nouchikusangiyou Shinko Jigyodan Whey beverage and its production
US5854029A (en) * 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent

Also Published As

Publication number Publication date
EP1287159A4 (en) 2005-02-09
EP1287159A1 (en) 2003-03-05
WO2001085984A1 (en) 2001-11-15
CA2415688A1 (en) 2001-11-15
NZ523036A (en) 2004-04-30
AU2001259625A1 (en) 2001-11-20
JP2004519204A (en) 2004-07-02

Similar Documents

Publication Publication Date Title
MXPA02011018A (en) Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals.
Guo et al. Optimisation of hydrolysis conditions for the production of the angiotensin-I converting enzyme (ACE) inhibitory peptides from whey protein using response surface methodology
Pedroche et al. Utilisation of chickpea protein isolates for production of peptides with angiotensin I‐converting enzyme (ACE)‐inhibitory activity
WO2008108649A3 (en) Ace-inhibitory peptides from whey and methods for providing the same.
AU5764098A (en) Method for producing a protein hydrolysate
MXPA06001173A (en) Analytical method for pancreatin and comparable compositions.
WO2002060474A3 (en) Mixtures of mushroom enzymes and the use thereof for treating maldigestion
DK1546316T3 (en) Mutant E. coli
CA2567582A1 (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
SG161247A1 (en) Variant forms of urate oxidase and use thereof
ATE397623T1 (en) ACE-INHIBITING WHEY HYDROLYSATES
WO2006060473A3 (en) Methods of treatment of injured or diseased joints with lubricin compositions
IL157414A0 (en) Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture
AU2125300A (en) Cyclosporin derivatives and method for the production of said derivatives
FR2608051B1 (en) PROCESS FOR THE MANUFACTURE OF AN ENZYMATIC HYDROLYSATE OF PROTEINS RICH IN DI- AND TRI-PEPTIDES, FOR USE IN PARTICULAR IN ARTIFICIAL NUTRITION AND DIETETICS
Seok et al. Change of protein and amino acid composition during Chungkook-Jang fermentation using Bacillus licheniformis CN-115
WO2005021762A3 (en) A process for proteolytic cleavage and purification of recombinant proteins produced in plants
WO2003087353A3 (en) Purified polypeptides involved in membrane biogenesis
WO2003070229A3 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
MXPA02010643A (en) A method of treating soy proteins and a soy protein product produced by this method.
AU2003248117A1 (en) Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them
PL338649A1 (en) Lactoferrin bonding neisseria protein
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
AU9066198A (en) Use of bromelain proteases for inhibiting blood coagulation
WO2001009292A3 (en) Sentrin-specific human proteases senp1-3